Ziovision
Ziovision is a South Korean AI company building video analytics and medical AI software for government public safety, defense, and hospital customers. Its products include the Zio-Summary LLM-based video summarization system, ZioKeeper child abuse detection deployed by Seoul Police, and MFDS-cleared ZIOMED medical devices.
- Company typePrivate
- Founded2020
- HeadquartersGangneung, South Korea
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Ziovision does
Ziovision (지오비전) is a privately held South Korean AI company founded around 2020, headquartered at the Gangwon National University campus in Chuncheon, with a Seoul office in the Guro Digital Innovation Park. The company operates a dual-track product portfolio. Its Social Safety AI line addresses CCTV-heavy public safety workflows: Zio-Summary is an LLM-based video summarization system that condenses 10-hour video into 20-minute summaries and is described as Korea's only such system; ZioVIS is a GS-Certification-Grade-1 intelligent selective monitoring system; ZioKeeper detects suspected child abuse through emotion and behavior recognition and has been deployed by the Seoul Metropolitan Police Agency; and ZioEdge is an edge-device form factor for small-scale monitoring. Its Medical AI line includes ZioMed (deep-learning diagnostic imaging), AI CDSS (intensive care unit clinical decision support), Smart Hospital (patient safety management), and a ZIOMED sub-brand of regulated medical devices (TUBA for nasogastric tube insertion, DeepPU for pressure ulcer risk, DeepTDM for drug concentration prediction, FaBoA for medical imaging, and JointMLP for drug injection management). Multiple ZIOMED products hold Korean MFDS approvals, medical device GMP, ISO 13485, and ISO 9001 certifications, and ZIOMED TUBA was the second product approved under the Digital Medical Products Act.
Ziovision sells through a direct enterprise and government field sales motion, primarily to Korean public-sector buyers (police, regional governments, administrative agencies, defense), university hospitals, and the military. Distribution is anchored in government procurement channels and hospital-direct sales, with defense procurement accessed through the Gangwon Defense Venture Center. Pricing is not publicly disclosed and the company's revenue model centers on software licensing, subscriptions, and regulated medical device sales, with sales handled via [email protected]. The company has raised approximately 15 billion KRW (~$2.6M USD) across multiple 2022-2024 Series A tranches led by Anda Asia Ventures, Honest Ventures, and the Korean Small Business Corporation, supplementing earlier TIPS Program support. It employs 11-50 staff and is led by CEO Kim Yun (김윤).
Strategically the company is in an early commercialization phase, with its first major public-sector contract (Seoul Metropolitan Police Agency) signed in May 2025, defense vertical expansion anchored by a October 2025 MOU with a national defense research institute, and US market entry supported by selection for the Global Innovation Special Zone program in October 2024. Research credibility is unusually strong for the size, including first place at ICCV AI City Challenge 2025 in multi-camera reasoning and 3D object tracking, and AAAI 2026 paper acceptance, but commercial revenue is not yet disclosed and the customer base remains narrow and concentrated.
Ziovision firmographics
Firmographics- Name
- Ziovision
- Legal name
- 주식회사 지오비전 (ZIOVISION Co., Ltd.)
- Website
- https://ziovision.co.kr
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Ziovision is a South Korean AI company building video analytics and medical AI software for government public safety, defense, and hospital customers. Its products include the Zio-Summary LLM-based video summarization system, ZioKeeper child abuse detection deployed by Seoul Police, and MFDS-cleared ZIOMED medical devices.
- Ownership category
- akta.pro rank
Ziovision industry classification
Industry- Product category
- AI Video Analytics and Medical AI Software
- NAICS
- Software Publishers (5132)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Video Analytics & AI Security Solutions Integration (LPR, Facial, Behavior) (BPAKAGAK)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
Keywords
Where Ziovision is headquartered
LocationHeadquarters
- HQ city
- Gangneung
- HQ country
- South Korea
- HQ region
- Asia
Offices2 records
Markets served
Ziovision business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- AI Software Licenses and Subscriptions: Ziovision generates revenue through licensing and subscription of its AI software products including Zio-Summary, ZioVIS, ZioKeeper, ZioEdge, ZioMed, AI CDSS, and Smart Hospital. Medical AI devices such as ZIOMED TUBA, ZIOMED DeepPU, ZIOMED DeepTDM, and ZIOMED-JointMLP have received regulatory approvals and certifications enabling commercial revenue generation.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Ziovision product offering
Product offeringCore offering
Ziovision develops and sells AI-powered video analytics and medical AI software for two main segments: Social Safety AI (video summarization, intelligent surveillance, child abuse detection, edge-based monitoring) and Medical AI (medical imaging diagnostics, ICU clinical decision support, and patient safety management). The products are sold primarily to government agencies, hospitals, and defense organizations in South Korea through direct sales and procurement channels.
Product overview
Ziovision offers a dual-track AI product portfolio spanning Social Safety AI and Medical AI. The Social Safety AI division includes Zio-Summary (video summarization system), ZioVIS (intelligent selective monitoring with GS Grade 1 certification), ZioKeeper (child abuse detection via emotion/behavior recognition), and ZioEdge (edge device-based monitoring). The Medical AI division encompasses ZioMed (AI diagnostic system), AI CDSS (clinical decision support for ICUs), and Smart Hospital (patient safety management). Ziovision has developed multiple specialized medical sub-products under the ZIOMED brand including DeepTDM (drug concentration prediction), DeepPU (pressure ulcer risk), TUBA (feeding tube detection), FaBoA (medical imaging analysis), and JointMLP (drug injection management).
Differentiator
Problem solved
Functional benefit
Brands
- Zio-Summary: Video summarization system that condenses 10-hour videos into 20-minute summaries - Korea's only video summarization system
- ZioVIS
- ZioKeeper
- ZioEdge
- ZioMed
- AI CDSS
- Smart Hospital
- ZIOMED DeepPU
- ZIOMED DeepTDM
- ZIOMED TUBA
- ZIOMED FaBoA
- ZIOMED-JointMLP
Products and services
- Zio-Summary (지오서머리)
- ZioVIS (지오비스) Intelligent selective monitoring system that instantly selects and monitors objects of interest from CCTV streams. Awarded GS Certification Grade 1. Deployed to government agencies for surveillance and public safety operations.
- ZioKeeper (지오지킴이) AI system that detects suspected child abuse situations through emotion and behavior recognition in video footage. Delivered to the Seoul Metropolitan Police Agency for child abuse video analysis.
- ZioEdge (지오엣지) AI-based individual and small-scale monitoring system using edge devices. Enables distributed AI surveillance for personal or small-scale deployments.
- ZioMed (지오메드) AI and deep learning-based medical diagnostic system encompassing multiple sub-products for facial bone fracture detection, pressure ulcer risk analysis, abnormal nasogastric tube insertion detection, drug concentration prediction, and medical image analysis. Used by hospitals and healthcare institutions.
- AI CDSS Artificial intelligence-based intensive care unit clinical decision support system for critically ill patients. Provides AI-driven decision support to ICU clinicians.
- Smart Hospital (스마트 병원) Patient safety management system for hospital environments, designed to monitor and manage patient safety in clinical settings.
- ZIOMED DeepTDM AI-based drug concentration prediction medical device that uses deep learning to predict drug concentration levels. Designated as an innovative medical device by Korean authorities.
- ZIOMED DeepPU Pressure ulcer occurrence risk analysis digital medical device using AI for hospital patient safety.
- ZIOMED TUBA AI-based software medical device for abnormal nasogastric (feeding) tube insertion detection. 2nd approval under Korea's Digital Medical Products Act.
- ZIOMED FaBoA Medical image analysis software for facial bone fracture detection using deep learning. Obtained medical device manufacturing certification.
- ZIOMED-JointMLP Drug injection management software using deep learning. Received Korea MFDS export approval for international distribution.
Quantifiable outcome
- Zio-Summary reduces 10-hour video to 20-minute summary
Companies that use Ziovision
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
Ziovision technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature8 records
Ziovision partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Kangwon National University Advanced Military Science and Technology Research Institute (강원대학교 첨단군사과학기술연구소)coreAI-based video analysis and defense application technology joint research MOU signed in October 2025 between Ziovision and the Kangwon National University Advanced Military Science and Technology Research Institute, focusing on AI-powered video analysis for defense scenarios.
- DR Tech (디알텍)coreMOU signed in May 2025 for joint commercialization of AI-based X-ray medical devices, combining Ziovision's AI technology with DR Tech's medical imaging hardware capabilities.
- Gangwon Defense Venture Center (강원국방벤처센터)coreZiovision selected as a partner company of the Gangwon Defense Venture Center, enabling participation in defense AI projects and military procurement programs.
- Global Innovation Special Zone Program (글로벌혁신특구)coreSelected for the Global Innovation Special Zone program in October 2024 to accelerate US market entry with government support.
- Kangwon National University Hospital (강원대학교병원)coreTripartite partnership with Kangwon National University Hospital and Gangdong Kyung Hee University Hospital for AI clinical decision support system development, leveraging hospital medical imaging data and clinical expertise.
- Gangdong Kyung Hee University Hospital (강동경희대학교병원)coreTripartite partnership with Kangwon National University Hospital and Gangdong Kyung Hee University Hospital for AI clinical decision support system development.
- Neo Able (네오에이블)minorCooperation agreement signed with Neo Able for collaborative partnership.
- Kangwon National University Hospital (강원대학교병원)coreMedical imaging AI deep learning research collaboration agreement signed in July 2020 with Kangwon National University Hospital, providing access to medical imaging data for AI model training.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Ziovision competitors and assessment
Company assessmentDirect peers
- Oosto (formerly AnyVision): Oosto provides AI video analytics including facial recognition, behavior detection, and watchlist alerting for security and public-safety deployments — closely comparable to ZioKeeper's emotion and behavior recognition for child abuse detection.
- IronYun (Vaidio): IronYun / Vaidio offers an AI video analytics platform covering object detection, behavior analysis, LPR, and people counting — directly parallel to Ziovision's social-safety AI feature set including behavior and emotion recognition.
- BriefCam: BriefCam is one of the closest direct peers: it specializes in AI-powered video analytics and video summarization for surveillance use cases — directly mirroring Ziovision's Zio-Summary and ZioVIS value propositions for security and public-safety customers.
- Lunit: Lunit is a Korean medical-AI company specializing in AI-powered imaging analysis for radiology and pathology, sharing Ziovision's ZioMed focus on CT, X-ray, and ultrasound diagnostic AI for hospitals.
- Agent Video Intelligence (Agent Vi): Agent Vi is an established AI video analytics vendor offering real-time anomaly detection, object tracking, and search across CCTV networks — directly comparable to Ziovision's social-safety product suite.
- Ambient.ai: Ambient.ai applies computer-vision AI to physical security camera feeds for threat detection and incident response in enterprise and government settings, sharing Ziovision's AI-on-CCTV positioning for public safety.
- VUNO: VUNO is a Korean medical-AI vendor with MFDS-cleared clinical decision support and imaging products — closely comparable to Ziovision's AI CDSS and ZIOMED portfolio serving Korean hospital customers.
- Verkada: Verkada combines cloud-managed physical security hardware with built-in AI video analytics for enterprises and public institutions — overlapping with Ziovision's intelligent selective monitoring (ZioVIS) and edge-based surveillance (ZioEdge).
Broad incumbents
- Hikvision: Hikvision is the world's largest CCTV and video-surveillance vendor, embedding AI analytics across its hardware-software stack — a broad incumbent whose AI capabilities overlap with Ziovision's CCTV-analytics products.
- SenseTime: SenseTime is a broad AI incumbent offering large-scale computer vision and video analytics for smart-city and surveillance applications, with substantially more capital and global reach than Ziovision's focused social-safety AI line.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Ziovision social profiles
Digital presenceZiovision compliance and trust
Trust signalCompliance3 records
Ziovision financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ziovision leadership team
Management profileNumber of profiles
Profiles3 records
Ziovision funding detail
Funding detailFunding overview
Funding rounds5 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ziovision M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ziovision
What does Ziovision do?
Ziovision develops and sells AI-powered video analytics and medical AI software for two main segments: Social Safety AI (video summarization, intelligent surveillance, child abuse detection, edge-based monitoring) and Medical AI (medical imaging diagnostics, ICU clinical decision support, and patient safety management). The products are sold primarily to government agencies, hospitals, and defense organizations in South Korea through direct sales and procurement channels.
Is Ziovision a public or private company?
Ziovision is a private company. It is classified as venture growth investor backed and is currently operating.
When was Ziovision founded?
Ziovision was founded in 2020. It employs 11 to 50 people.
Where is Ziovision based?
Ziovision is headquartered in Gangneung, South Korea, in the Asia region.
How does Ziovision make money?
One revenue line is on record: AI Software Licenses and Subscriptions.
Who are Ziovision's main competitors?
Direct peers on record are Oosto (formerly AnyVision), IronYun (Vaidio), BriefCam, Lunit, Agent Video Intelligence (Agent Vi), Ambient.ai, VUNO and Verkada. Broad incumbents are Hikvision and SenseTime.
Does Ziovision have an API?
No public API is recorded for Ziovision.
What industry is Ziovision in?
Ziovision's product category is AI Video Analytics and Medical AI Software. Its primary akta.pro industry code is BPAKAGAK, Video Analytics & AI Security Solutions Integration (LPR, Facial, Behavior), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 5132 and its SIC code is 3845.